Cardiost

Cardiost is dedicated to developing intellectual property in the cardiovascular field and commercializing its researched and developed medical devices. Currently, Cardiost is developing a durable mechanical circulatory support (MCS) device for treating patients with advanced heart failure, a chronic condition that currently affects 7.8 million Americans and over 32 million patients worldwide.